Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.

The future of high-grade glioma: Where we are and where are we going. Surg Neurol Int (2015) 1.50

Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices. Brain Stimul (2011) 1.45

Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). BMC Med Phys (2009) 1.32

Predicting the electric field distribution in the brain for the treatment of glioblastoma. Phys Med Biol (2014) 1.32

Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int (2014) 1.18

Transcranial alternating current stimulation (tACS). Front Hum Neurosci (2013) 1.17

Cancer cell proliferation is inhibited by specific modulation frequencies. Br J Cancer (2011) 1.17

Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs. Clin Exp Metastasis (2009) 1.15

Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. J Exp Clin Cancer Res (2009) 1.10

Mild electrical stimulation with heat shock ameliorates insulin resistance via enhanced insulin signaling. PLoS One (2008) 1.08

Greater osteoblast proliferation on anodized nanotubular titanium upon electrical stimulation. Int J Nanomedicine (2008) 1.04

Contributors to contrast between glioma and brain tissue in chemical exchange saturation transfer sensitive imaging at 3 Tesla. Neuroimage (2014) 0.98

TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters. BMC Cancer (2010) 0.97

Standards of care and novel approaches in the management of glioblastoma multiforme. Chin J Cancer (2014) 0.95

Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS One (2015) 0.94

The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system. World J Surg Oncol (2014) 0.94

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields. World J Surg Oncol (2012) 0.94

Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells. Sci Rep (2015) 0.93

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. Br J Cancer (2015) 0.92

Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma. Cancer Med (2014) 0.91

Strong synergy of heat and modulated electromagnetic field in tumor cell killing. Strahlenther Onkol (2009) 0.91

Electric fields generated by synchronized oscillations of microtubules, centrosomes and chromosomes regulate the dynamics of mitosis and meiosis. Theor Biol Med Model (2012) 0.90

Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment. Cancer (2013) 0.89

Influence of reactive species on the modification of biomolecules generated from the soft plasma. Sci Rep (2015) 0.88

A three-dimensional in vitro tumor platform for modeling therapeutic irreversible electroporation. Biophys J (2012) 0.88

The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study. Phys Med Biol (2015) 0.88

Microbial growth inhibition by alternating electric fields in mice with Pseudomonas aeruginosa lung infection. Antimicrob Agents Chemother (2010) 0.87

Microbial growth inhibition by alternating electric fields. Antimicrob Agents Chemother (2008) 0.86

Targeted cellular ablation based on the morphology of malignant cells. Sci Rep (2015) 0.84

Electric field stimulation through a biodegradable polypyrrole-co-polycaprolactone substrate enhances neural cell growth. J Biomed Mater Res A (2013) 0.84

Differential Effects of Cold Atmospheric Plasma in the Treatment of Malignant Glioma. PLoS One (2015) 0.84

Advancing practical usage of microtechnology: a study of the functional consequences of dielectrophoresis on neural stem cells. Integr Biol (Camb) (2012) 0.84

An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas. Curr Treat Options Oncol (2015) 0.83

Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme. PLoS One (2016) 0.83

NovoTTF(™)-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL(™) system user study. World J Surg Oncol (2015) 0.82

Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo. Int J Cancer (2016) 0.81

Individual differences in transcranial electrical stimulation current density. J Biomed Res (2013) 0.81

Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis. Oncotarget (2016) 0.80

Engineering a 3D microfluidic culture platform for tumor-treating field application. Sci Rep (2016) 0.80

Mild electrical stimulation at 0.1-ms pulse width induces p53 protein phosphorylation and G2 arrest in human epithelial cells. J Biol Chem (2013) 0.80

Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation. Oncotarget (2016) 0.80

Recurrent malignant gliomas. Semin Radiat Oncol (2014) 0.79

An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma. Curr Neurol Neurosci Rep (2016) 0.78

Electro-acoustic behavior of the mitotic spindle: a semi-classical coarse-grained model. PLoS One (2014) 0.78

Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells. Cancer (2014) 0.78

Could radiotherapy effectiveness be enhanced by electromagnetic field treatment? Int J Mol Sci (2013) 0.78

Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies. Chin J Cancer (2013) 0.78

A toy model of fractal glioma development under RF electric field treatment. Eur Phys J E Soft Matter (2012) 0.78

Radiofrequency currents exert cytotoxic effects in NB69 human neuroblastoma cells but not in peripheral blood mononuclear cells. Int J Oncol (2012) 0.78

TTFields: where does all the skepticism come from? Neuro Oncol (2016) 0.78

The effects of non-invasive radiofrequency treatment and hyperthermia on malignant and nonmalignant cells. Int J Environ Res Public Health (2014) 0.78

Tumor treating fields: a novel treatment modality and its use in brain tumors. Neuro Oncol (2016) 0.78

Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement. BMC Cancer (2016) 0.77

Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI. J Neurooncol (2015) 0.77

Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study. PLoS One (2016) 0.76

Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment. Cancer Lett (2015) 0.76

Non-contact method for directing electrotaxis. Sci Rep (2015) 0.76

Biological activity of tumor-treating fields in preclinical glioma models. Cell Death Dis (2017) 0.75

Effects of substrate conductivity on cell morphogenesis and proliferation using tailored, atomic layer deposition-grown ZnO thin films. Sci Rep (2015) 0.75

Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines. Cell Death Dis (2017) 0.75

Biophysical insights into cancer transformation and treatment. ScientificWorldJournal (2013) 0.75

The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells. J Clin Neurosci (2016) 0.75

Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology. Cancer Med (2016) 0.75

Murine model of neuromuscular electrical stimulation on squamous cell carcinoma: potential implications for dysphagia therapy. Head Neck (2011) 0.75

Living in a material world: tumor-treating fields at the top of the charts. Neuro Oncol (2016) 0.75

A novel miniature dynamic microfluidic cell culture platform using electro-osmosis diode pumping. Biomicrofluidics (2014) 0.75

An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields. Int J Environ Res Public Health (2016) 0.75

Chronic inflammation: is it the driver or is it paving the road for malignant transformation? Genes Cancer (2015) 0.75

Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma. J Vis Exp (2014) 0.75

Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study. PLoS One (2017) 0.75

Low-intensity alternating electric fields: a potentially safe and effective treatment of cancer? Onkologie (2008) 0.75

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields). J Vis Exp (2017) 0.75

Tumor Treating Fields in Neuro-Oncological Practice. Curr Oncol Rep (2017) 0.75

Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol (1990) 18.71

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol (1999) 8.69

Studies of Thermal Injury: II. The Relative Importance of Time and Surface Temperature in the Causation of Cutaneous Burns. Am J Pathol (1947) 6.84

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96

Phase II trial of gefitinib in recurrent glioblastoma. J Clin Oncol (2003) 3.83

Disruption of cancer cell replication by alternating electric fields. Cancer Res (2004) 2.62

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol (2001) 2.39

Characterization of electric field-induced fusion in erythrocyte ghost membranes. J Cell Biol (1984) 1.81

Ca(2+)-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol Lett (1992) 1.16

The development and application of pulsed electromagnetic fields (PEMFs) for ununited fractures and arthrodeses. Clin Plast Surg (1985) 1.16

Transmembrane calcium influx induced by ac electric fields. FASEB J (1999) 1.09

Dielectrophoretic manipulation of macromolecules: the electric field. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.06

Temozolomide in the treatment of recurrent malignant glioma. Cancer (2004) 1.04

Electrorotation and dielectrophoresis. Parasitology (1998) 1.03

Alignment of microscopic particles in electric fields and its biological implications. Biophys J (1985) 1.03

Electrorotation of colloidal particles and cells depends on surface charge. Biophys J (1997) 1.02

The distribution of radiofrequency current and burns. Anesthesiology (1973) 1.02

Contact dermatitis in hospital patients. Dermatol Clin (1990) 0.96

Morphometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats. J Neurooncol (1999) 0.95

Harnessing dielectric forces for separations of cells, fine particles and macromolecules. J Chromatogr A (2005) 0.92

Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J Pharm Sci (1988) 0.90

Stimulation of muscles and nerves by means of externally applied electrodes. Bull Res Counc Isr Sect E Exp Med (1962) 0.87

Comparison of iodotyrosines and methionine uptake in a rat glioma model. J Nucl Med (1998) 0.87

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med (2009) 6.73

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60

Oscillations and variability in the p53 system. Mol Syst Biol (2006) 4.59

Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med (2006) 4.38

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer (2012) 3.66

Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke (2006) 3.49

Proteome half-life dynamics in living human cells. Science (2011) 3.34

Adaptive prediction of environmental changes by microorganisms. Nature (2009) 3.19

Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature (2011) 3.08

NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest (2013) 2.96

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest (2010) 2.89

Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm (2010) 2.89

IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest (2007) 2.88

Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol (2008) 2.83

IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol (2007) 2.73

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med (2012) 2.71

Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. J Clin Oncol (2005) 2.70

Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest (2004) 2.65

Disruption of cancer cell replication by alternating electric fields. Cancer Res (2004) 2.62

Diverse two-dimensional input functions control bacterial sugar genes. Mol Cell (2008) 2.60

Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity (2007) 2.58

Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med (2009) 2.45

Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance. Arthritis Rheum (2012) 2.43

Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity (2005) 2.35

Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol (2004) 2.27

Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol (2002) 2.17

Cost of unneeded proteins in E. coli is reduced after several generations in exponential growth. Mol Cell (2010) 2.17

The incoherent feed-forward loop can generate non-monotonic input functions for genes. Mol Syst Biol (2008) 2.13

Cutting edge: Priming of NK cells by IL-18. J Immunol (2008) 2.08

Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut (2012) 1.97

Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect (2004) 1.94

NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood (2004) 1.88

Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med (2010) 1.84

NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout. Arthritis Rheum (2012) 1.83

Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity (2012) 1.82

Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol (2004) 1.81

Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infect Immun (2004) 1.77

The mirror game as a paradigm for studying the dynamics of two people improvising motion together. Proc Natl Acad Sci U S A (2011) 1.76

Protein dynamics in drug combinations: a linear superposition of individual-drug responses. Cell (2010) 1.75

VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases. Proc Natl Acad Sci U S A (2007) 1.68

Both hemopoietic and resident cells are required for MyD88-dependent pulmonary inflammatory response to inhaled endotoxin. J Immunol (2005) 1.59

Collective nitric oxide production provides tissue-wide immunity during Leishmania infection. J Clin Invest (2014) 1.58

IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol (2011) 1.57

iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog (2009) 1.53

Mode of regulation and the insulation of bacterial gene expression. Mol Cell (2012) 1.53

Reactivation of latent tuberculosis infection in TNF-deficient mice. J Immunol (2003) 1.52

A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet (2005) 1.51

Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc Natl Acad Sci U S A (2005) 1.50

Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet (2008) 1.49

Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion. Mov Disord (2005) 1.48

Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J Immunol (2010) 1.44

TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa. J Immunol (2010) 1.43

Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J Immunol (2007) 1.41

Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog (2010) 1.39

The Geriatric Scoring System (GSS) in meningioma patients--validation. Acta Neurochir (Wien) (2011) 1.39

Intractable gelastic seizures during infancy: ictal positron emission tomography (PET) demonstrating epileptiform activity within the hypothalamic hamartoma. J Child Neurol (2007) 1.39

Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study. Lancet Oncol (2008) 1.39

Murine cerebral malaria development is independent of toll-like receptor signaling. Am J Pathol (2007) 1.38

Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am J Respir Crit Care Med (2011) 1.38

Overexpression of Toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice. J Immunol (2003) 1.36

Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther (2014) 1.35

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem (2012) 1.35

MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol (2008) 1.32

Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). BMC Med Phys (2009) 1.32

Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol (2011) 1.32

IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS One (2011) 1.32

IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol (2009) 1.31

Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial. J Clin Oncol (2003) 1.28

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer. J Gene Med (2003) 1.27

Defined order of evolutionary adaptations: experimental evidence. Evolution (2008) 1.26

Promoters maintain their relative activity levels under different growth conditions. Mol Syst Biol (2013) 1.26

Inflammasome-IL-1-Th17 response in allergic lung inflammation. J Mol Cell Biol (2011) 1.25

Cost-benefit theory and optimal design of gene regulation functions. Phys Biol (2007) 1.25

Invariant distribution of promoter activities in Escherichia coli. PLoS Comput Biol (2009) 1.24

The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J Immunol (2005) 1.23

All-trans retinoic acid promotes TGF-β-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS One (2011) 1.20

Fourier analysis and systems identification of the p53 feedback loop. Proc Natl Acad Sci U S A (2010) 1.19

IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol (2009) 1.17

Diffusion and partition of solutes in cartilage under static load. Biophys Chem (2003) 1.15

Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. Int J Exp Pathol (2007) 1.15

Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs. Clin Exp Metastasis (2009) 1.15